Drugs / Prostavasin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01378845 Comparator | Jul 2011 → Jun 2015 | Raynaud disease | Christoph Hehrlein | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prostavasin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01378845 ↗ |
| Route | Intravenous | “Prostavasin 60 µg i.v, 5 days per week for 2 weeks” NCT01378845 ↗ |